Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$789,143
+$92,306 QoQ
Shares Held
3,136
-2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#2,774
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026McLean Asset Management Corp holds $5,605,267 across 9 Drug Manufacturers - General names. ABBV ranks #3 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,420 | $1,703,190 | |
| 2 | JNJ |
Johnson & Johnson
|
3,218 | $817,275 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
3,136 | $789,143 | |
| 4 | AZN |
Astrazeneca PLC
|
3,240 | $614,368 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,870 | $497,295 | |
| 6 | AMGN |
Amgen Inc
|
1,064 | $385,295 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,472 | $372,916 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,768 | $223,369 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $789,143 | 3,136 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $696,837 | 3,204 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $709,232 | 3,104 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $762,924 | 3,295 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $609,390 | 3,283 | Shares | Sole | 2025-07-03 | |
| 2025-03-31 | $660,616 | 3,153 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $566,863 | 3,190 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $675,974 | 3,423 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $499,809 | 2,914 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $513,704 | 2,821 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $433,451 | 2,797 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $440,323 | 2,954 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $369,699 | 2,744 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $463,926 | 2,911 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $537,514 | 3,326 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $411,622 | 3,067 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $479,543 | 3,131 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $490,544 | 3,026 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $422,854 | 3,123 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $384,880 | 3,568 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $273,377 | 2,427 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $247,932 | 2,291 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $236,372 | 2,206 | Shares | Sole | 2021-01-27 | |
| No filing history on record for this holder in this stock. | ||||||